- Home
- FBP vs TLX Comparison
FBP vs TLX Comparison
Compare FBP & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBP
- TLX
- Stock Information
- Founded
- FBP 1948
- TLX 2015
- Country
- FBP United States
- TLX Australia
- Employees
- FBP N/A
- TLX N/A
- Industry
- FBP Major Banks
- TLX Biotechnology: Pharmaceutical Preparations
- Sector
- FBP Finance
- TLX Health Care
- Exchange
- FBP Nasdaq
- TLX Nasdaq
- Market Cap
- FBP 3.5B
- TLX 3.2B
- IPO Year
- FBP N/A
- TLX N/A
- Fundamental
- Price
- FBP $21.82
- TLX $9.15
- Analyst Decision
- FBP Buy
- TLX Strong Buy
- Analyst Count
- FBP 3
- TLX 3
- Target Price
- FBP $24.00
- TLX $21.33
- AVG Volume (30 Days)
- FBP 915.9K
- TLX 263.1K
- Earning Date
- FBP 10-22-2025
- TLX 01-01-0001
- Dividend Yield
- FBP 3.28%
- TLX N/A
- EPS Growth
- FBP 2.67
- TLX N/A
- EPS
- FBP 1.88
- TLX 0.04
- Revenue
- FBP $890,993,000.00
- TLX $664,225,558.00
- Revenue This Year
- FBP $13.22
- TLX N/A
- Revenue Next Year
- FBP $5.71
- TLX N/A
- P/E Ratio
- FBP $11.66
- TLX $218.57
- Revenue Growth
- FBP 1.81
- TLX 55.35
- 52 Week Low
- FBP $16.40
- TLX $8.93
- 52 Week High
- FBP $22.61
- TLX $30.36
- Technical
- Relative Strength Index (RSI)
- FBP 50.99
- TLX 32.93
- Support Level
- FBP $21.59
- TLX $8.94
- Resistance Level
- FBP $22.10
- TLX $9.74
- Average True Range (ATR)
- FBP 0.38
- TLX 0.29
- MACD
- FBP -0.05
- TLX 0.01
- Stochastic Oscillator
- FBP 19.61
- TLX 6.58
About FBP First BanCorp. New
First BanCorp is a financial holding company. The company's operating segment includes Commercial and Corporate Banking; Mortgage Banking; Consumer (Retail) Banking; Treasury and Investments; United States Operations; and Virgin Islands Operations. It generates maximum revenue from the Consumer (Retail) Banking segment. The Consumer (Retail) Banking segment generates majority revenue, which consists of the Corporation's consumer lending and deposit-taking activities conducted mainly through its branch network and loan centres. Geographically, it derives a majority of revenue from Puerto Rico.
About TLX Telix Pharmaceuticals Limited American Depositary Shares
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.